ADAM17 and systemic lupus erythematosus: In the context of autoimmune diseases, aberrant ADAM17 activity has been linked to elevated TNF-α levels and chronic inflammation in conditions such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), psoriasis, and Crohn’s disease.